Comparison of patients with poor ovarian response included in the antagonist cycle during standard, dual and triple triggering in IVF outcomes
Not Applicable
Recruiting
- Conditions
- Infertility.infertilefertility
- Registration Number
- IRCT20230702058644N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 108
Inclusion Criteria
informed consent to participate in the study
Age between 24-42 years old
Body mass index of 19-27
The presence of POR (AFCI <7, AMH <1.5)
Eligibility of the patient for IVF
The absence of uterine abnormalities
Exclusion Criteria
Hypothalamic dysfunctions in the patient
diabetes mellitus
liver diseases
heart diseases
renal diseases
epilepsy
metabolic disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of good quality embryos. Timepoint: 3 days after fertilization. Method of measurement: High-quality cleavage stage embryos will have six cells or greater on day 3 and less than 10% fragmentation and symmetric blastomeres, according to the Istanbul consensus workshop.
- Secondary Outcome Measures
Name Time Method umber of retrieved oocytes. Timepoint: 36 hours after triggering. Method of measurement: All oocyte retrievals will be performed under transvaginal ultrasound guidance and will be counted using light microscopy.;The number of mature oocytes. Timepoint: 36 hours after triggering. Method of measurement: All oocyte retrievals will be performed under transvaginal ultrasound guidance and the number of mature oocytes will be counted using light microscopy.;The number of clinical pregnancies. Timepoint: the presence of gestation sac two weeks after a positive hCG blood test. Method of measurement: ultrasound scan.;Implantation rate. Timepoint: at 6–7 weeks of pregnancy. Method of measurement: Implantation rate is calculated from the number of gestational sacs with a visible fetal heart on ultrasound scan divided by the total number of transferred embryos.